BusinessImportant JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core TechnologyBy Nasdaq OMXApr 3, 2018, 11:38 AM UTC
BusinessPositiveID Announces 2017 Highlights and Projects Continued 30% GrowthBy Nasdaq OMXJan 10, 2018, 1:00 PM UTC
BusinessPositiveID’s ExcitePCR Named Major Player in Molecular Diagnostics Industry ReportBy Nasdaq OMXDec 14, 2017, 1:01 PM UTC
BusinessPositiveID Announces Highlights for the Third Quarter of 2017By Nasdaq OMXOct 9, 2017, 12:00 PM UTC
BusinessPositiveID’s ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel TodayBy Nasdaq OMXSep 18, 2017, 1:00 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
